Poolbeg Pharma Ownership
| POLBF Stock | USD 0.04 0.00 0.00% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Poolbeg |
Poolbeg Pink Sheet Ownership Analysis
About 20.0% of the company outstanding shares are owned by corporate insiders. The company had not issued any dividends in recent years. Poolbeg Pharma plc operates as a clinical stage infectious disease pharmaceutical company in the United Kingdom. Poolbeg Pharma plc was incorporated in 2021 and is headquartered in London, the United Kingdom. Poolbeg Pharma operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 7 people.The quote for Poolbeg Pharma PLC is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Poolbeg Pharma PLC contact Jeremy Skillington at 44 20 7183 1499 or learn more at https://www.poolbegpharma.com.Currently Active Assets on Macroaxis
Other Information on Investing in Poolbeg Pink Sheet
Poolbeg Pharma financial ratios help investors to determine whether Poolbeg Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Poolbeg with respect to the benefits of owning Poolbeg Pharma security.